Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Says Emerging Market Drugs to Generate 25% of 2013 Revenue
Bloomberg
Tuesday, January 11, 2011 - 12:43pm
tags:
Merck, emerging markets
Merck Reports FDA Acceptance of NDA for Janumet
Bloomberg
Tuesday, January 11, 2011 - 12:41pm
tags:
Merck, FDA, Janumet, NDA, diabetes
CVRs could become a new trend in biotech M&A
Marketwatch
Tuesday, January 11, 2011 - 12:33pm
tags:
CVRs, biotech, M&A, Genzyme, Sanofi
Qiagen Buys Stake in German Start-Up, Gaining Biomarker Access
Bloomberg
Tuesday, January 11, 2011 - 12:32pm
tags:
Qiagen, biomarkers, Germany, Alacris Theranostics GmbH
Celgene's Drop Could Provide a Great Opportunity
Seeking Alpha
Tuesday, January 11, 2011 - 12:31pm
tags:
Celgene, earnings
Charge This! A Fired Merck Sales Rep & A Credit Card
Pharmalot
Tuesday, January 11, 2011 - 12:29pm
tags:
Merck, drug reps
Galapagos updates progress in GSK arthritis trials
Marketwatch
Tuesday, January 11, 2011 - 12:28pm
tags:
GSK, Galapagos, arthritis
Human Genome sets Lupus drug sales goal
Marketwatch
Tuesday, January 11, 2011 - 12:27pm
tags:
lupus, Human Genome Sciences, Benlysta
Endo Pharma shares drop as FDA rejects application
Yahoo/AP
Monday, January 10, 2011 - 8:13pm
tags:
FDA, Endo, Opana ER
Opko Teams Up With Bristol-Myers For Alzheimers Effort
Forbes
Monday, January 10, 2011 - 8:12pm
tags:
OPKO Health, Alzheimer's disease, Bristol-Myers Squibb
Amgen Exec: “Clearly Superior” Prostate Cancer Drug Will Be Huge
Forbes
Monday, January 10, 2011 - 8:04pm
tags:
prostate cancer, Amgen, Prolia, Xgeva
Will Drug Repurposing Mean Healthy Profits?
Seeking Alpha
Monday, January 10, 2011 - 7:28pm
tags:
drug repurposing, Celgene, Merck, Pfizer
Epizyme, Glaxo sign deal worth up to $650M
Bizjournals.com
Monday, January 10, 2011 - 7:27pm
tags:
Epizyme, GSK, personalized medicine
Medicare contractor won't stop paying for Avastin
Fierce Pharma
Monday, January 10, 2011 - 12:40pm
tags:
Avastin, Medicare, Roche, Genentech, breast cancer
Sanofi Is Discussing Lemtrada Payments With Genzyme
Bloomberg
Monday, January 10, 2011 - 12:38pm
tags:
Sanofi, Lemtrada, Genzyme, MS, multiple sclerosis
InterMune to start new IPF drug trial
Bizjournals
Monday, January 10, 2011 - 12:37pm
tags:
IPF, InterMune, Esbriet
Exelixis cancer drug wins 'orphan' tag
Bizjournals.com
Monday, January 10, 2011 - 12:35pm
tags:
Exelixis, orphan drugs, XL-184, thyroid cancer
New Langer startup to develop oral insulin
Bizjournals.com
Monday, January 10, 2011 - 12:27pm
tags:
insulin, diabetes, Entrega
Vertex Expects an Eventful 2011
Yahoo/Zacks.com
Monday, January 10, 2011 - 12:26pm
tags:
Vertex Pharmaceuticals, JNJ
Bristol-Myers, Pharmasset plan hepatitis C study
Yahoo/AP
Monday, January 10, 2011 - 12:23pm
tags:
hepatitis C, Pharmasset, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.